Open access · CC-BY
via OpenAlex
Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial
Jack Feehan, Alexandra Mack, Caroline J. Tuck, Jorge Tchongue, Darcy Quinn Holt, William Sievert, Gregory Thomas Moore, Barbora Vozarova de Courten, Alexander D. Hodge
Nutrients · 2023 · ▲ 40 citations
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is associated with visceral adiposity. We assessed the effectiveness of time-restricted fasting (TRF) for 16 h daily without calorie restrictions compared to standard care (SC; diet and lifestyle advice) in improving visceral adiposity and steatosis via controlled attenuation parameter (CAP). Methods: In a prospective single-blind randomized controlled trial, 32 participants with NAFLD were randomly assigned to TRF or SC for 12 weeks. The secondary endpoints were changes in liver stiffness, anthropometry, blood pressure, and other metabolic factors. Results: Twenty-eight participants completed the first arm of the study (TRF = 14, SC = 14), with 23 completing the crossover arm (TRF = 10, SC = 13). The baseline demographics were similar between the groups. Intermittent fasting caused a significant decrease in hepatic steatosis (p = 0.038), weight (p = 0.005), waist circumference (p = 0.001), and BMI (p = 0.005) compared to standard care. Intermittent fasting also resulted in additional within-group changes that were not seen in the standard care intervention. Conclusion: TRF offers superior improvements in patients with NAFLD, improving steatosis, weight, and waist circumference despite a lack of change in overall caloric intake. Time-restricted fasting should be considered as a primary weight loss intervention in the context of NAFLD. Trial registration: ACTRN12613000935730.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/nu15234870
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Feehan, J., Mack, A., Tuck, C.J., Tchongue, J., Holt, D.Q., Sievert, W., Moore, G.T., Courten, B.V.D., & Hodge, A.D. (2023). Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial. <em>Nutrients</em>. https://doi.org/10.3390/nu15234870
Vancouver
Feehan J, Mack A, Tuck CJ, Tchongue J, Holt DQ, Sievert W, et al. Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial. Nutrients. 2023. doi:10.3390/nu15234870.
BibTeX
@article{jack2023TimeRe,
title = {Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial},
author = {Jack Feehan and Alexandra Mack and Caroline J. Tuck and Jorge Tchongue and Darcy Quinn Holt and William Sievert and Gregory Thomas Moore and Barbora Vozarova de Courten and Alexander D. Hodge},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15234870},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Gastroenterology 2019
Open access · CC-BY
Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial
University Hospital, Antwerp 2024
Open access · US-GOV
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
JHEP Reports 2020
Open access · CC-BY
Gut dysbiosis as a driver in alcohol-induced liver injury
Emory University 2016
Open access · US-GOV
Prospective Comparison of Technology-based Eye Care Services (TECS) With and Without OCT Assessment Versus Standard Face to Face Ophthalmologic Exam
Clinical Infectious Diseases 2018
Open access · OA
Gut Dysbiosis Associated With Hepatitis C Virus Infection
The University of Hong Kong 2025
Open access · US-GOV